Kreatech, Oridis Team on DNA-FISH Assays | GenomeWeb

NEW YORK (GenomeWeb News) – Kreatech Diagnostics and Oridis Biomarkers today said that they will co-develop and commercialize DNA-FISH assays for oncology applications.

The firms intend to develop the assays as companion diagnostics for pharmaceutical firms conducting pre-clinical and clinical development of new compounds. Amsterdam, The Netherlands--based Kreatech said that it expects to begin commercializing assays in the second half of this year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.